In a phase 3 trial of patients with dedifferentiated liposarcoma, the CDK4/6 inhibitor extended progression-free survival more than sixfold.
Medscape Medical News
Source link : https://www.medscape.com/viewarticle/abemaciclib-slows-progression-advanced-liposarcoma-2026a1000i2g?src=rss
Author :
Publish date : 2026-05-31 16:30:00
Copyright for syndicated content belongs to the linked Source.
